It can be difficult and daunting to evaluate patients with chronic pain, as the nervous system is complex and knowing which type of pain the patient is experiencing – neuropathic, nociceptive, or nociplastic – is the best guide for where clinicians should focus their treatment choices; the fact that there is no clinical way to diagnose sensitization only adds to the difficulty. It’s important for clinicians to think of what the actual mechanisms of a medication are and how to use them in a rational way to help decrease pain.
There is rarely a medication that will decrease pain completely, but patients should at least experience positive effects on their level of function and quality of life. Dr. Steven Stanos discusses the importance of providing the right expectations for patients, “You have to set the right expectation for the patient. If the patient has a poor understanding of their pain condition, there is this thought that is not accurate – that we can give a medicine for everything. There is rarely a medicine that is going to decrease their pain completely. It’s important to tie the pain score to functional outcomes – what can they now be doing?”
In this free CME Snack, Dr. Gold and Dr. Stanos focus on the pathophysiology of pain and the underlying mechanisms to assessment and appropriate management and share insights on ways to properly educate patients about their pain to optimize safe and effective multimodal treatment plans.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
Supported by an educational grant from Johnson & Johnson.
Physicians, physician assistants, nurse practitioners, nurses, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Gold has no disclosures to report.
Dr. Stanos reports that he receives research support from Grunenthal and is a consultant for SCILEX Pharmaceuticals, Inc.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.